Rigel's R548 in Organ Transplant Rejection - Oral JAK Inhibitor

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
563 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 2, 2011

Rigel's oral Janus Kinase 3 (JAK3) inhibitor program is focused on organ transplant rejection. JAK3 is critical to immune system activation and is an attractive target because its expression is limited to key cells in the immune system.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Very good explained!

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more